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Background: Pregnancy Induced Hypertension (PIH) and its complications contribute to a significant 
burden of disease both in developed and developing countries of the world. Unfortunately, PIH has no 
cure, the delivery of the baby and the placenta is required. Early detection of pregnancy induced 
hypertension and close monitoring remains the key to achieving a favourable outcome. This study 
aimed to determine the quality of care given to women diagnosed with Pregnancy Induced Hypertension 
(PIH) within a care pathway spanning peri-urban primary and urban secondary level facilities. 
 
Methods: This was a retrospective clinical audit of medical records of patients diagnosed with PIH. It 
was conducted in the Wesfleur -New Somerset Hospital drainage area, using a locally validated data 
extraction tool, based on the South African Maternal Care Guidelines. The data were analyzed using 
descriptive methods to report on the frequencies and proportions of the variables, and analyzed to report 
on statistical significance of correlations.  
 
Results:   The prevalence rate of pregnancy induced hypertension in this study was 12%. 
The overall pregnancy induced hypertension complication prevalence in the study for mothers was 
7.7%, and that of babies was 30.7%. 
Facilities generally performed well according to the audit indicators detailing structures and processes 
that should be followed, as outlined by the standard guidelines used. 
Two process indicators were correlated with adverse outcomes: 66.1% of patients were appropriately 
referred, resulting in statistically better foetal outcomes (p = 0.059); and those who booked early in the 
pregnancy had less PIH-induced complications than those who booked late (p = 0.012)  
 
Conclusion:  This study followed a standardized audit methodology and found that the quality of care 
in this peri-urban area is of a good standard and identified areas for quality improvement and further 
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Maternal mortality is unacceptably high. About 830 women die from pregnancy or childbirth-related 
complications around the world every day. It was estimated that In 2015, roughly 303,000 women died 
during and following pregnancy and childbirth. Almost all of these deaths occurred in low-resource 
settings, and most could have been prevented (1). 
Pregnancy induced hypertension (PIH) is a foremost cause of maternal death, with early detection and 
management being important to achieving favorable outcomes. PIH is the commonest pregnancy-
induced complication affecting the mother-fetus dyad (2). Annually, it has been estimated that 
hypertensive disorders (HD) in pregnancy resulted into 50,000 maternal deaths, and the vast majority 
of them occurred in low-income or middle-income countries. Approximately 25% of the cases result in 
uterine growth restriction, and 15% result in preterm birth in developed countries (2). It predisposes the 
baby to fetal death, Abruptio placentae and fetal distress. The mother is predisposed to increased risk 
factor of cardiovascular diseases, renal failure, liver damage, pancreatitis, pulmonary edema, eclampsia, 
arrhythmia and type 2 diabetes in later life (3). 
Epidemiology of pregnancy induced hypertension 
Hypertensive disorders of pregnancy and its complications contribute to a significant burden of disease 
both in developed and developing countries of the world (4). According to the Guidelines for Maternity 
Care in South Africa, A manual for clinics, community health centers and district hospitals (fourth 
edition, 2015), the term “pregnancy induced hypertension” is defined as new onset of hypertension BP 
> 140/90mmhg, on two separates occasions at least 6 hours apart, occurring after 20weeks of gestation 
without significant proteinuria (5) . Pre-eclampsia and eclampsia are ranked second after hemorrhage 
as an explicit and direct cause of maternal death globally (4). The main causes leading to death were 
cerebral hemorrhage and pulmonary edema, therefore focus should be placed on the immediate 
lowering of acute severe hypertension and policy of restrictive fluid loading (6). Annually, about 
500,000 babies died of the condition (7). In the developing countries, and in Africa in particular, these 
patterns tend to be repeated, and some instances, exaggerated. 
 
In developing countries, the risk of a woman presenting with PIH is seven times higher compared to 
their counterparts in  developed countries, and with 10-25% of these cases possibly resulting in maternal 
death, this represents an important  preventable cause of maternal mortality and subsequent opportunity 
for intervention (8). In African studies, PIH occurred in 10% of pregnancies when compared to the 
global average of approximately 2% (9). A study conducted in Mulago Hospital (Kampala, Uganda) 
showed that the two major causes of maternal death were PIH and obstructed labor and their 
complications (9). In the developing world, severe forms of preeclampsia and eclampsia is common, 
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ranging  from a low of 4% of all deliveries to as high as 18% in parts of Africa (10).  By comparison, 
in the United State, preeclampsia and hypertensive disorders of pregnancy account for 5-8% of all births 
(10). In Zimbabwe, the maternal and perinatal mortality study conducted in 2007 found PIH to be a 
common causes of maternal mortality, and third highest reason for referral in labor  (11).  The effects 
of PIH on complications of pregnancy are well documented. 
The selected maternal and newborn morbidities such as increased caesarean deliveries, abruptio 
placentae, and acute renal dysfunction, respiratory distress syndrome, ventilatory support, and fetal 
growth restriction were significantly greater in women with hypertension (11). PIH also contributes 
significantly to low birth weight. Women who delivered low birth weight babies were 5 times more 
likely to have developed pregnancy induced hypertension(11).  
 
The local context of PIH care 
According to the Saving Mothers report 2014-2016: seventh triennial report on the confidential 
enquiries into maternal death in South Africa entered by 15th May 2017 (12). there were 661 deaths in 
the last triennium (2014-2016) with an increase in the number of deaths of 21 since the 2011-2013 
triennium (640); (12). 
Maternal deaths due to Obstetric hemorrhage and hypertension in 2014-2016 accounted for 34.8% of 
all deaths (16.9% and 17.9% respectively (12).The report shows that poor quality of care is a leading 
cause of  maternal death from pre-eclampsia (12). The report recommends controlling of high blood 
pressure in a high care setting, with close monitoring using standard methods outlined in the Maternity 
care Guidelines of South Africa (12). Understanding this burden of disease and extrapolating lessons 
from the global context could assist in improving maternal and fetal outcomes. 
If one compares local figures with developed countries, indications are that pre-eclampsia is still a major 
global health concern. In the United Kingdom, hemorrhage accounted for 15% of Obstetric-related 
maternal deaths, while  hypertensive disorders of pregnancy accounted for 10% (13). In California , 
maternal death resulting from preeclampsia /eclampsia amounted to 15%, while deaths secondary to 
obstetric hemorrhage amounted to 10% (14). High income countries have employed a strategy to reduce 
both the incidence of eclampsia and mortality associated with it by almost 90% by utilizing a 
combination of early detection during antenatal care and increased access to hospital care for women 




Current knowledge of PIH 
PIH has no cure, the delivery of the baby and the placenta is required. However, early diagnosis, active 
management of the blood pressure, and close observation is vital  for controlling the condition during 
pregnancy(15).  
 To prevent any disease process, it requires a method for prediction of those at high risk for the disorder 
(16). It is recommended to have a clinical and biochemical test for prediction or early detection of PIH, 
but majority remain ineffective for general use in most developing countries (16). Some studies on 
uterine artery Doppler and first trimester maternal serum markers for early detection of PIH have been 
conducted, there is no convincing proof for general use in clinical practice, less so in resource poor 
settings (16). At present, no single reliable and cost effective screening test for pregnancy induced 
hypertension can be recommended for use (16).  
Case finding is dependent on the presence of the diagnostic criteria: New onset of hypertension  BP > 
140 / 90mmhg, on two separates occasions at least 6 hours apart, presenting after 20weeks of gestation 
without significant proteinuria;  the diagnosis of Pre-eclampsia (hypertension with significant 
proteinuria developing for the first time after 20weeks of gestation; or the presence of   Eclampsia 
(patient experiences a generalized tonic-clonic seizure after 20 weeks of pregnancy and within 7 days 
after delivery, associated with hypertension and proteinuria) (12). The diagnosis is made when some 
biological damage has already occurred as evidenced by the clinical abnormal parameters, putting the 
mother-baby dyad at risk. To allow effective case finding, a number of important factors need to be 
addressed. 
To tackle the problem of PIH effectively in any population by identifying those at risk and diagnosing 
early in the disease progression especially in poor under-resourced communities, a functional, 
accessible health care system is imperative (17). However, a significant number of developing countries 
particularly in Africa have limited health care access due to a number of factors, resulting in three levels 
of delay that is primary, secondary and tertiary level (17). There is a delay in the decision to seek care, 
poverty, and the rising cost of health care (17). Some socio-demographic factors play a vital role, for 
example, the level of education, the marital status and cultural beliefs which has aided maternal health-
seeking behavior (18). Delay in reaching health facility or lack of access to quality of care has been the 
main obstacle to reducing maternal mortality in low-income countries (19). A study conducted in 
Nigeria showed that 50% of rural women live more than 5km from the nearest hospital, with no formal 
means of transportation  except by walking even when in labor (19). A consequence of this phenomenon 
is that lack of access has contributed to high patronage of faith healing and alternative medical 
practitioners resulting in delays in referral which has accounted for 46.4% of all cases of eclampsia in 
this context (20). 
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It has been suggested that strengthening the health care system is vital in order to address this issue 
(21). Political commitment to mobilize necessary resources to the health sector with the view of 
improving the quality of emergency Obstetric services should be emphasized, it entails presence of a 
trained personnel, drugs, and equipment at every level of care (21). Access to emergency obstetric care 
should be prompt and affordable to limit delays when skills or facilities are lacking (21). A systematic 
approach to measuring these systemic issues is useful when considering quality improvement.  
A quality improvement cycle aimed at improving the health care response to preeclampsia was carried 
out in California in 2013. The report shows that about 40% of patients with new onset of hypertension 
or new onset of proteinuria, in this study, went on to develop classic pre-eclampsia (22). The overall 
mortality rate for preeclampsia in this study was greater than 2 times that of the UK, largely due to 
differences in death caused by stroke (22). Controlling blood pressure was correctly seen as an 
important intervention to  prevent deaths due to stroke in women with preeclampsia (22). The quality 
improvement analysis showed that despite clear triggers indicating serious deterioration in the patient’s 
condition, health care professionals often failed to recognize and respond to these clinical signs in a 
timely manner (22). In fact, missed vital sign “triggers” occurred in 60% of the preeclampsia deaths 
(22). The health care professionals tended to minimize signs and symptoms and missed opportunities 
to alter the outcome (22). The conclusion from the study was that an organized tool to identify clinical 
signs or triggers could aid clinicians to recognize and respond in a more timely manner to avoid delays 
in diagnosis and treatment (22). A significant reduction in pregnancy induced hypertension was also 
seen in rural China and Sri Lanka. In 2011, Ronsman and Campbell showed that routinely screening 
pregnant women for hypertension and proteinuria is beneficial. Treating severe preeclamptic patients 
with antihypertensive and anticonvulsant drugs and, if necessary ending the pregnancy by inducing 
labor or carry out caesarean delivery is beneficial especially in low-income countries (23). 
If the diagnosis of PIH is made at a community clinic, the Guideline for Maternal Care in South Africa 
stipulates that the advice of an experienced doctor should be obtained to establish if any immediate 
treatment, investigations, timing of referral and monitoring are required. The patient is checked for 
proteinuria, edema, and increased weight gain, to see if pre-eclampsia has developed in the meantime. 
If PIH is confirmed. The patient needs ultrasound assessment of the fetal well-being. Blood pressure 
should be controlled at values of 135-140mmhg systolic and 85-90mmhg diastolic (5). This entails the 
following: 
• Patient may require antihypertensive therapy which is based on individual case. If needed for 
mild to moderate pre-eclampsia, methyldopa 250-500mg eight hourly orally is given. 
• If patient is less than 38wks, can be managed on an outpatient basis at the high-risk antenatal 
clinic on a weekly basis and should be seen by the same experienced doctor or midwife at each 
visit. Delivery can be delayed until 39weeks if assessed by a specialist. 
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• If the patient with PIH develops proteinuria, increasing weight gain or there is decreased fetal 
movements, then she should be reassessed and delivered. 
• Severe pre-eclampsia or imminent eclampsia patient should be stabilized and have immediate 
transfer to a specialist (regional or tertiary) hospital. Magnesium Sulphate (MgSO4) 
prophylaxis should be initiated against the development of seizures. Methyldopa 500mg should 
be administered orally. If acute severe hypertension [systolic >/= 160mmhg systolic, or 
Diastolic >/=110 mmHg], the patient should be given Nifedipine 10mg orally as a stat dose and 
monitored continuously until the ambulance arrives. A second dose of Nifedipine and 
MgSO4can be considered based on the patient’s response.  
Rationale for this study 
While much epidemiological studies have been done in describing the burden of disease of pregnancy 
induced hypertension, few studies have looked at the quality improvement in antenatal care of patients 
with PIH. In urban Cape Town, South Africa, there is no documented attempt at improving the quality 
of care in this area. This study, in the form of a clinical audit, will be the basis of a quality improvement 
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Chapter 2: Publication-ready manuscript 
Introduction and Literature review 
Maternal mortality is alarming, with a significant amount of women dying from pregnancy or childbirth 
related complications around the world every day (1). Pregnancy induced hypertension (PIH) is a 
leading cause of maternal death, early diagnosis and management is the key to achieving favorable 
outcomes (2). Hypertensive disorders of pregnancy is responsible for a substantial burden of disease in 
developed and developing countries of the world. They are the leading cause of maternal and perinatal 
mortality and morbidity worldwide (3). In developing countries, the risk of a woman presenting with 
PIH is seven times higher compared to their counterparts in  developed countries, this being a 
preventable cause of maternal mortality (4). 
The recently published guidelines on the management of hypertensive disorders in pregnancy (HDP) 
highlighted the concerning trends in maternal deaths in South Africa (5). Although 78% of deaths 
occurred at a higher level of care, many of the emergencies are thought to have originated at the primary 
healthcare (PHC) or the district hospital (DH) level (5). Avoidable factors for HDP deaths were 
identified in 48% and 60% of the case at the Community Health Centre (CHC) and DH level, 
respectively(5). The factors identified at a PHC and DH included inadequate assessment, errors in 
diagnosis, delayed or no referrals to higher levels of care, non-adherence to management protocols, 
poor monitoring and poor response to abnormal monitoring(5). 
Reproductive, maternal, newborn and child health has been a priority for both governments and civil 
society in low-and middle-income countries. This priorities was affirmed by world leaders in the 
millennium development goals (MDG) that called for countries to reduce child mortality by 67 percent 
between 1990 and 2015 (6). Although substantial progress on these targets has been made, few countries 
achieved the needed reductions. Poor reproductive health outcomes for women and their children may 
result from broad spectrum of morbid conditions and adverse circumstances and risk factors, such as 
unsafe sex leading to unwanted pregnancies and sexually transmitted infections, as well as violence 
against women and girls (6). In addition, the underlying causes of perinatal mortality includes maternal, 
fetal and health system factors. 
Despite global progress in reducing maternal mortality, immediate action is required to begin making 
progress towards the ambitious sustainable development goals (SDG) and ultimately eliminating 
preventable maternal mortality (7).The year 2015 marks the start of the sustainable development goals 
(SDG) which include the global target of less than 70 maternal deaths per 100 000 live births globally 
by 2030 with no country exceeding twice the global MMR of 140 maternal deaths per 100 000 live 
births (7). 
The projection suggest that the achievement of the SDG maternal mortality target would result in 60.1% 
fewer maternal deaths in the year 2030 and 1.4million fewer deaths cumulatively from 2016 to 2030 
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(7). The pay-off of achieving the SDG target is clear on the projected reduction in the number of 
maternal deaths, much work is needed at a country-level to accomplish this ambitious goal in the coming 
15years (7).  
The required acceleration will not be possible without a combination of interventions and actions taken, 
along the lines of the concerted efforts taken by countries that succeeded in bringing about a substantial 
maternal mortality decline in a short period of time (7). Each country context will be different, the 
ending of a preventable maternal mortality strategy suggests for adaptive, highly effective interventions 
to improve women’s health before, during and after pregnancy (7). 
Maternal factors shown to adversely affect pregnancy outcomes include maternal age (younger than 
19yrs and older than 35yrs show increased complication rates), maternal infections, low nutritional 
status, low socio-economic and educational status, short inter-pregnancy interval (less than 2 years), 
rural residence, medical co-morbidities (Anemia, Diabetes Mellitus, HIV), and PIH-related 
complications. Most neonatal deaths are related to complications of birth asphyxia, low birth weight, 
septicemia, congenital malformation and preterm deliveries (6). Complications of undiagnosed and 
under-treated PIH impact on maternal and fetal outcomes negatively. 
PIH is well documented to cause complications in mothers and in the fetus. Deaths from hypertensive 
disorders of pregnancy occur in all categories of hypertensive disorders with eclampsia and pre-
eclampsia being the commonest final causes of death (5). The main causes leading to death were 
cerebral hemorrhage and pulmonary edema, therefore focus should be placed on the immediate 
lowering of acute severe hypertension and policy of restrictive fluid loading (5). Such steps will reduce 
the percentage of preventable deaths, assessed to be approximately 70% in the period 2014-2016 (5). 
Unfortunately, no progress has been made in the last decade in reducing the deaths due to hypertensive 
disorders of pregnancy (5). 
The saving mothers report on confidential enquiries into maternal deaths in South Africa 2017: showed 
the following findings: Preterm Delivery rates 14.7%, IUGR 2.4%, Renal Failure 17.2%, Eclampsia 
52.5%, HELLP Syndrome 12.9%, Pulmonary Edema 34.34%, Abruptio 6.3%, Fetal Death 24.4% (8). 
A prospective observation study was conducted in Obstetrics and Gynecology Department at Ghulam 
Muhammed Mahar Medical College and Hospital from Jan 1st to Dec 31st in Pakistan. PIH prevalence 
was 23.2%. The fetal complications include Preterm delivery 30%, Fetal Distress 20%, Intrauterine 
Death 27.3%, Low Birth Weight 30%, and IUGR 10%. Maternal complications includes Postpartum 
Hemorrhage  PPH 29%, Pulmonary Edema 28.5%, and Placental Abruptio 47.3% (9). In comparison, 
Eclampsia, Pulmonary edema and Preterm delivery is still a major complication that needs attention. 
Health system issues like impaired access to good quality antenatal, intrapartum and post-partum care 
have been identified as significant factors affecting pregnancy outcomes (6). The combined delivery of 
linked health interventions proved to be a more effective way of achieving common health goals than 
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working independently (6). To tackle the problem of PIH effectively in any population, an accessible, 
proactive, evidence-based health care system is imperative (10). In an African context, where delay in 
the decision to seek care, poverty, and the rising cost of health care impacts directly on pregnancy 
outcomes, this is an urgent project (10).  
There are still significant shortcomings in the management of these life-threatening emergencies 
because of lack of skills and knowledge as evidenced in two local studies (11, 12). 
Managing hypertensive disorders in pregnancy (HDP) requires knowledge and skills, and the best way 
to obtain such competencies is through educational initiatives such as Essential Steps in Managing 
Obstetric Emergencies (ESMOE) (13).  Participating in regular emergency obstetric simulations (fire 
drills) at workplace allows primary care providers the opportunity to identify gaps in their knowledge 
and skills, and recognize and address shortcomings in equipment and drug stocks (13). 
While much epidemiological studies have been done in describing the burden of disease of pregnancy 
induced hypertension, few studies have looked at quality improvement in antenatal care of patients with 
PIH. In urban and peri-urban Cape Town, South Africa, there is no documented attempt at improving 
the quality of care in this area. This study, in the form of a clinical audit, will be the basis of a quality 
improvement project in the antenatal care pathway for patients with PIH in the Wesfleur- New Somerset 
Hospital drainage area. 
 
Aim and objectives 
The aim of this study was to assess the quality of antenatal care for patients with PIH in the Wesfleur-
New Somerset Hospital drainage area. This entails early identification of complications, with a 
subsequent significant decrease in the maternal and perinatal mortality rate. 
In fulfilling this aim, the following objectives were set:  
 To describe the demographic profile of patients diagnosed with PIH. 
 To determine the prevalence of PIH. 
 To evaluate the standard of care at Basic Antenatal Care (BANC) sites. This includes documenting on 
the antenatal record chart, all clinical information and results of special investigations as well as changes 
that may occur during pregnancy, and the level of care that is needed. Each facility should have its own 
specific protocols for the management of obstetric conditions which must be in line with the South 
African national maternity care guidelines, it should be displaced in the facility. 







The study was designed as a retrospective review of clinical records using clinical audit methodology.  
Study site 
The study was conducted within the care pathway for pregnant patients in the Wesfleur Hospital 
(Atlantis)-New Somerset Hospital axis in Cape Town, South Africa, and included primary care 
antenatal sites providing Basic Antenatal Care (BANC) services in the Atlantis area. Atlantis is a peri-
urban working-class community with a population of 67 491, with low socio-economic status (70% of 
households with a combined income of <R76 400/annum, with an average of 4.3 people/household), 
situated on the Western extreme of Cape Town, about 55km from the city centre. This area is served by 
a number of nurse-led primary care clinics. There is a small Family Physician-run hospital (Wesfleur 
Hospital) providing the only birthing unit in this area and 24hr emergency obstetric services. The 
secondary-level referral hospital, New Somerset Hospital, is about 50km away by road. In very specific 
emergencies, emergency helicopter services transport patients to the referral hospital (14). 
Study population and sampling  
The population being studied were women diagnosed with PIH in the specified geographic area. The 
sample for this study included all patients who had been diagnosed with PIH or any of its complications, 
at any level of care in the Primary care-Wesfleur-New Somerset care pathway over a 6- month period 
(March 2017 – August 2017). As all patients who fit the criteria were included, there was no need to 
use a sampling strategy. The exclusion criteria were patients with pre-existing chronic hypertension. 
All patients who delivered within the 6- month study period, and fit the inclusion criteria, formed the 
study population. Birth registers at Wesfleur and New Somerset hospitals were used to compile a list 
of potential cases and clinical records accessed to confirm eligibility. A total of 65 eligible patients were 
identified, all of whom were enrolled in the study. A total of 541 births were recorded for this area 
during the period under review.  
Data Collection and Analysis 
An audit team comprising a Family Medicine registrar, two Family Medicine consultants, nursing and 
administrative staff at Wesfleur Hospital, was constituted. Specialist obstetricians within the referral 
network were asked to review and comment on various aspects of the project. 
Prior to commencement of data collection, an audit tool was developed using the Donabedian approach 
of measuring Structure-Process-Outcome as separate domains (15). Face and content-validity was 
established by getting the tool reviewed by Senior Family Physicians and Obstetricians who are familiar 
with the Maternal Care Guidelines and are senior clinicians within the care pathway. Thereafter, a small 
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pilot study was conducted to test reliability. Using the finalised tool, the researcher extracted data from 
the folders directly onto an Excel spread sheet, transferred it to the statistics software, STATISTICA 
version 12 (16) for analysis by a biostatistician. The data is reported as means and confident intervals 
for each key outcome. Correlations were calculated between dependant variables (maternal and fetal 
complications) and independent variables (all other variables). Correlations were deemed significant 
when p<0.05.  
  
Ethical Considerations 
The National Health Act requires that an informed consent should be obtained from every research 
participant before the commencement of the research. However, as this is a retrospective audit of 
clinical records, consent to access the records was given by the hospital authorities. 
In compliance with the World Medical Associations Declaration of Helsinki that states that every 
precaution must be taken to protect the privacy of research subjects and confidentiality of their personal 
information (17), all study data was anonymized and stored on a password protected computer that was 
only accessible to the research team. 
Ethical Approval for the research proposal was obtained from the Human Research Ethics Committee 
(HREC ref.: 845/2017) of the University of Cape Town, and the Provincial Research Committee of the 
Department of Health, Western Cape Government, granted access approval. Permission to review the 
records was obtained from the hospital management and clinical staff being audited.  
 
Results 
During the study period (March 2017-Aug 2017), a total of 541deliveries were registered in the Atlantis 
area. Sixty-five (n=65) women were diagnosed with PIH and received related care in the Wesfleur-New 
Somerset Hospital Axis. All of them were included in this study. This gives a prevalence rate of 12% 
for PIH in this population. PIH maternal complications were recorded in 7.7% of the study population, 
while the fetal complications were documented in 30.7% of cases.  
Those below the age of 20 formed 23.1% of the patients while those above 40 years accounted for 1.5%. 
As depicted in Table 1 below, maternity records showed that coloured patients formed majority of the 
sample (78.5%), followed by black patients (18.5%) with white and Indian patients accounting for the 
minority of the study (1.5% each). There was no indication in the clinical records to determine how 
these racial classifications were assigned. The majority of the women were unemployed (73.8%). More 
than three quarters of the patients were single (76.9%), 21.5% married, and 1 patient (1.5%) was 
divorced.  59 (90.8%) of the cohort were booked for antenatal care. Gravidity ranged from 1 to 5, with 
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primigravidae accounting for 47.6% (31/65) while 53.1% (34/65) were multi-gravida (2 or more 
previous pregnancies).  
 
 
Table 1. Socio-demographic characteristics of the study sample 
 
 Total sample N=65  
Variables N % 
Age-group 
< 20yrs 15 23.1 
20-29yrs 25 38.5 
30-39yrs 24 36.9 
40yrs and above 1 1.5 
Race 
Black 12 18.5 
White 1 1.5 
Coloured 51 78.5 
Indian 1 1.5 
Marital status 
Single 50 76.9 
Married 14 21.5 
Divorced 1 1.5 
Employment status 
Employed 17 26.2 
Unemployed 48 73.8 
Booking status 
Booked 59 90.8 
Un-booked 6 9.2 
Gravidity 
1 31 47.6 
2 12 18.8 
3 11 17.2 
4 4 6.3 
5 7 10.9 
 
 
In Table 2 below, of the 65 pregnant patients 35.4% (23/65) smoked cigarettes. Very few had a 
comorbid condition (3.1%), although 16.9% (11/65) had a positive family history of hypertension, 3.1% 
(2/65) had documented family history of diabetes, and none had a family history of a combination of 
both. 36.9% (24/65) of the patients had a BMI less of 25 or lower, while 53.8% (35/65) had a BMI of 
26 and above. Roughly one third of patients (35.4 %) had a previous history of obstetric complications. 
There were no twin pregnancies. 
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Table 2. Risk profile pattern of the study sample 
                                                                 
 Total sample          
N= 65 
Variables N % 
Smoking status 
Yes 23 35.4 
No 42 64.6 
Comorbid Condition                     
Present 2 3.1 
Absent 63 96.9 
Family History                  
Hypertension 11 16.9 
Diabetes 2 3.1 
Hypertension and Diabetes 0 0 
BMI                           
26 and above 35 53.8 
25 and below 24 36.9 
Unknown 6 9.2 
Previous history of Obstetric Complication 
Yes 23 35.4 





The structural indicators ascertained the availability of key resources needed to deliver antenatal 
services at a primary care facility. All primary care facilities in Atlantis (n=4) were audited for readiness 
to diagnose, treat and refer patients with PIH. It was found that all clinics had all the resources in place 
to deliver the service. 
 
Table 3. Structure indicators of the audited facilities. 
 
 Total facilities N=4                    % 
Copy of Clinical Practice 
Guideline available in the 
facility 
                   4 100 
Availability of equipment                    4 100 
For basic ANC   
BP machine and cuff sizes                    4 100 
   Urine dipstix                    4 100 
  Weighing scale                    4 100 




Evaluation of the process indicators showed that high levels of compliance with best practice, as defined 
by the Maternal Care Guideline. There were lapses on timely referring patients with the condition. Only 
66.1% of patients with the condition were timely referred. Also, majority of the delivery took place via 
caesarean section with the percentage of 52.3%.  The total number of 6 women with PIH delivered at 
Wesfleur hospital and subsequently transferred to New Somerset Hospital for stabilisation, while 59 of 
the women with PIH had the delivery at New Somerset Hospital.  
 
Table 4. Process indicators at Wesfleur Hospital Atlantis- New Somerset Hospital Axis. 
 
Process indicator Total sample (n=65) % completed and recorded  
Weight 65 100 
Urine dipstix 65 100 
Blood Pressure 65 100 
Diagnosis based on clinical data 65 100 
Appropriate referrals 43 66.1 
Baseline investigation for 
Haemoglobin 65 100 
Platelet 65 100 
Creatinine 65 100 
Urea 65 100 
AST 65 100 
Protein concentration in Urine 
1 18 27.7 
2 39 61.9 
3 8 12.7 
Mode of delivery 
Vaginally 31 47.7 
Caesarean section 34 52.3 
 
Maternal complications occurred in 5 women, 4 of whom had more than one complication. As shown 
in Table 5, eclampsia occurred in 4.6%, renal complications in 7.7%, and pulmonary edema in 3.1% of 
the entire sample. Fetal complications as shown in Table 5, intrauterine growth restriction occurred in 
12.3%, fetal distress in 26.2%, and preterm delivery in 23% of the entire sample. There were no 
maternal or fetal deaths in the current sample. 
   
Table 5: Complications profile of the study sample 
 
 Total sample N=65 % 
Maternal complications 
Overall maternal complications 5 7.7 
HELLP Syndrome 4 6.2 
Eclampsia 3 4.6 
Stroke 0 0 
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Renal Failure 5 7.7 
Pulmonary Oedema 2 3.1 
>1 complication 4 6.2 
Maternal death 0 0 
Fetal Complications 
Overall fetal complications 20 30.7 
IUGR 8 12.3 
Fetal Distress 17 26.2 
Abruptio Placenta 0 0 
Preterm Delivery 15 23 
Fetal death 0 0 
Booking status was significantly associated with PIH complications, in those not booked with p = 0.37 
vs p = 0.012 in those being booked.  
Understandably, delivery mode was significantly associated with fetal distress (p = 0.001), with 42.4% 
of distressed babies born via C-section compared to only 6.5% of babies born via vaginal birth.  
No significant associations were found between presence of PIH and age (p = .881), employment (p = 
.778), relationship status (p = .333), gravidity (p = .831), smoking (p = .697), BMI (p = .626), previous 
obstetric complication (p = .697), or mode of delivery (p = .264). 
Discussion 
In this study, the prevalence of PIH was 12%. Globally, the PIH prevalence rates varies from country 
to country and has been reported to occur as low as 0.51% to as high as 38.4%(18) . In African studies, 
PIH occurred in 10% of pregnancies, which is significantly higher than the global average of 
approximately 2% (19). In South Africa, PIH prevalence was found in 18% of all pregnancies (5) . Two 
hospital based studies in sub-Saharan Africa had prevalence of 11.5 and 26.5%(20).  In Ethiopia, the 
prevalence ranges from 1.2 % to 18.25% (21). In United States of America, 7-10% of all pregnancies 
are complicated by PIH (22). In China, it was estimated at 5.2%(23).  
 PIH prevalence rates in India was reported as 7.8% (24). while in Iran it was 9.8% (25).  In Sweden, 
prevalence rates have been reported as  1.5% and 7.5% in Brazil  (26, 27). The result of our study 
supported the conclusion that PIH prevalence is higher in developing countries when compared to 
developed countries. The reason being that access of women to antenatal care and emergency obstetric 
care is limited in developing country. Most women showed up in health facilities when symptoms are 
serious. The result from our study also showed a slight increase of 2% when compared to the average 
in African studies. 
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 Given that prevalence rates elsewhere ranges from 2-20%, this low prevalence could represent a 
deficiency in the case finding methodology used (likely, as all women giving birth made use of the 
facilities in this study), an underdiagnosis by the attending clinicians (likely, as all facilities scored very 
well on clinical process indicators), or be a true reflection of this population’s epidemiological profile. 
If this prevalence estimate is true, this population has one of the lowest rates reported in the literature 
anywhere in the world, and this would warrant further epidemiological investigation. 
 
The prevalence of PIH complications is as follows: The overall maternal complications in our study 
was 7.7%, while that of fetal complications occurred in 30.7% of all children. This is comparable to the  
global picture, where about 10% of all women with PIH experience related complications (28).The 
prevalence is similar in Zimbabwe which accounts for 19.4% of pregnancies (29). The result from our 
study showed a slight reduction of 2.3% when compared to the global average. 
The effects of inappropriate referral and un-booked patients diagnosed with PIH cannot be over 
emphasized. In this study, early booking was associated with lower complications (p= 0.012).This  
finding is corroborated by studies elsewhere in the world that found improved maternal (any PIH 
complication) and fetal outcomes (IUGR and intra-uterine death) due to early use of antenatal services.   
Similarly, appropriate referral was associated with improved fetal outcomes. This underscores the need 
for early booking in pregnancy for early identification and prompt management of problems. 
The complication profile of our study showed two positive outcomes. There were no fetal or maternal 
deaths. The fetal complications were dominated by preterm delivery 38.5%, fetal distress 26.2% and 
IUGR 12.3%. On the other hand, maternal complications were favorably comparable to that found 
elsewhere in the developing world, as demonstrated in Table 6 below. The Saving Mothers report on 
confidential enquiries into maternal deaths in South Africa 2017: showed the findings Preterm Delivery 
14.7%, IUGR 2.4%, Renal Failure 17.2%, Eclampsia 52.5%, HELLP Syndrome 12.9%, Pulmonary 
Edema 34.34%, Abruptio 6.3%, Fetal Death 24.4%(8). In  Ethiopia, a prospective study was carried out 
in the referral hospital at Mettu Karl, it recorded the following maternal outcomes: Renal failure 7%, 
Abruptio 2%, Liver failure 12%, HELLP 12.4%,  Eclampsia 19%, while the unfavorable fetal outcomes 
were preterm delivery at 31%, fetal distress 18.5%, with no maternal and fetal deaths reported (30) . 
The outcomes of another prospective study which reviewed 112 deliveries with PIH  conducted in 
Pakistan are as follows: pulmonary edema 28.5%, Abruptio was 47.3%, fetal distress 20%, IUGR 10%, 
preterm delivery 30% ,Eclampsia 15.8%, HELLP Syndrome 8.3% (9). However a prospective study 
conducted in India recorded both maternal and fetal mortalities with the following maternal outcomes: 
2.12% maternal death,  6.3% renal failure, HELLP 10.63%, Eclampsia 9.8% the fetal outcome were as 
follows: 19.14% had IUGR, fetal distress 24.19 % (31). A retrospective case control study was 
conducted in Taiwan on women with PIH , the outcome was Preterm delivery 77.7%,  Renal failure 
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1.23%, Eclampsia 9.37%, Pulmonary Edema 2.38%, HELLP Syndrome 9.3%, Abruptio 4.96%, 
Maternal death 1%, Fetal death 8.82% (32).  A retrospective study was conducted in Haiti in women 
with PIH, the findings showed Preterm delivery 15.6%, Fetal distress 20%, IUGR 10%, Eclampsia 
23.3%, Pulmonary Edema 28.5%, Abruptio 47.3%, Maternal death 0.3%, Fetal death 4.9% (33).  An 
analytical cross sectional study was conducted in Zimbabwe on women with PIH, the findings was 
preterm delivery 14.3%, Eclampsia 2.1%, Fetal death 5.4% (29). 
Prematurity was more frequent among women with pregnancy induced hypertension PIH. The present 
study result showed no stillbirth, but highlighted prematurity, fetal distress as the main perinatal 
consequences. 
A prospective study done in Ethiopia, Pakistan and the retrospective study in Taiwan observed similar 
patterns in perinatal outcomes. This is in contrast to study done in Haiti and Zimbabwe with lower 
percentage. Prematurity increases perinatal morbidity and mortality rates with possible immediate or 
late sequels, this indicate a room for improvement and suggest that optimal care delivered in a low-
resource setting should continue to be an important focus for future clinical studies. 
In this study, no maternal death was recorded. This is in conformity with the study conducted in 
Ethiopia, Pakistan. A minimal percentage was recorded in Haiti, Taiwan, and India. 
In contrast to other studies done in Ethiopia, Pakistan, Haiti where majority of patients had Eclampsia, 
we found out that small percentage in our study had Eclampsia. This is in consistent with the study 
conducted in Zimbabwe, India, Taiwan. 
 
 








Ethiopia Pakistan India Taiwan Haiti Zimbabwe 
Preterm 
Delivery 
38.5% 14.7 31% 30% NR 77.7 15.6 14.3 
Fetal 
Distress 
26.2% NR 18.5% 20% 24.19% NR 20 NR 
IUGR 12.3% 2.4 NR 10% 19.14% NR 10 NR 
Renal 
Failure 
7.7% 17.2 7 NR 6.3% 1.23 NR NR 
Eclampsia 4.6% 52.5 19% 15.8% 9.8% 9.37 23.3 2.1 
HELLP 
Syndrome 
6.2% 12.9 12.4% 8.3% 10.63% 9.3 NR NR 
Pulmonary 
Edema 
3.1% 34.34 NR 28.5% NR 2.38 28.5 NR 
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Abruptio 0 6.3 2% 47.3% NR 4.96 47.3 NR 
Liver 
Failure 
0 NR 12% NR NR NR NR NR 
Maternal 
Death 
0 NR 0 0 2.12% 1 0.3 NR 
Fetal death 0 24.4 NR NR NR 8.82 4.9 5.4 
 
Strengths 
The study documented care along a pathway and did not restrict its focus to a single facility only. This 
represents a novel approach to clinical audit, providing rationale for good quality primary care in terms 
of accessibility, decision-making and efficient referral. In addition, this is the first time that a study has 
evaluated a peri-urban to urban clinical pathway for this high-risk group of patients. 
A standardized methodology was implemented in the study design, and national guidelines were used 
to develop a data collection tool, making this a valid and reliable study for reproduction in other parts 
of South Africa. 
Although the study sample was small, it represented the entirety of the population at risk, and the 
findings can therefore reliably be used to comment on the quality of services in this area.  
Limitations 
In any study whose data is derived from clinical records, the completeness of the dataset is dependent 
on the completeness of the clinical record. As such, the data quality of the study may have been 
adversely affected. 
The nature of clinical audits is that they are site-specific and cannot be extrapolated to the general 
population. However, it must be added that generalisation is never the aim of a study of this nature, 
rather it is to provide commentary on the quality of the clinical services. 
 
Many of the outcomes described in this study can be multifactorial. To determine if they are definitively 
related to the presence of PIH, a much larger sample size would be needed, and data analysis would 
need to include multiple logistic regression to determine correlations. 
 
While the review of the clinical records was thorough, this study did not do any longer- term follow-up 
on any of the patients. This would have provided additional useful information about the long-term 
sequelae of PIH-related complications. 
 




Future research should explore system deficiencies related to delayed referral and inadequate record 
keeping in more details, with particular attention to the resources allocated to maternity services, as 
well as the subjective experiences of staff working in these services. 
Late or non-booking by patients is a perennial problem and warrants research attention to understand 
contextual and personal factors impacting patient decision-making and health-seeking behaviour.  
 
Conclusion 
Hypertensive disorders of pregnancy constitute a substantial burden of disease in both developed and 
developing countries of the world, with significant pregnancy complications. 
 
The structural indicators ascertained the availability of key resources needed to deliver antenatal 
services at primary care facility. The evaluation of the process indicators showed that high levels of 
compliance with best practice, as defined by the maternal care guideline. 
 
The complication profile of our study showed two positive outcomes. There were no fetal or maternal 
deaths. Two process indicators were correlated with adverse outcomes: 66.1% of patients were 
appropriately referred, resulting in statistically better fetal outcomes. (p=0.059) and those who booked 
early in the pregnancy had less PIH complications than those who booked late (p=0.012). 
 
We piloted a useful audit tool to assess quality of district-level care in patients with PIH, showing that 
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                                                        Data extraction tool: 
 
                                  VARIABLES Coding 
                                  AGE GROUP  
                                                                       < 20yrs 1 
                                                                    20-29yrs 2 
                                                                    30-39yrs 3 
                                                      40yrs and above 4 
                                   RACE  
                Black 1 
               White 2 
                Colored 3 
               Indian 4 
                          MARITAL STATUS  
              Single 1 
             Married 2 
              Divorced 3 
Widowed 4 
            BOOKING   STATUS  
                  Booked 1 
                Un-booked 0 
            EMPOLYMENT STATUS  
                     Yes 1 
                     No 0 
            SMOKING STATUS  
                     Yes 1 
                      No 0 
          FAMILY   HISTORY   OF HYPERTENSION 
 
 
                          Yes 1 
                         No 0 
                   DIABETES  
                        Yes 1 
                        No 0 
      HYPERTENSION   AND DIABETES  
                         Yes 1 
                           No 0 
        PRE-EXISTING RENAL DISEASE   
Yes 1 
No 0 





BODY MASS INDEX (BMI)  
< 25 1 
25 and above 2 
Unknown 3 





                           5 and above  
PREVIOUS OBSTETRIC COMPLICATION  
                             Yes 1 
No 0 
                    STRUCTURE  
(1)   Any available standard guideline to 
manage patients with PIH AT MOU?  
                                     Yes 1 
No 0 
(2) Availability of equipment for basic ANC   
(a)Blood Pressure Machine and cuff sizes  
Yes 1 
No 0 
    (b)Urine Dipstix     
Yes 1 
No 0 
(C) Weighing   Scale  
Yes 1 
No 0 
(d)  Tape measure  
Yes 1 
No 0 
                                         PROCESS  
   (1)  Was the patient checked for the 
following each visit?  
                   (a)      Weight  
                                 Yes 1 
                                                                                                  
No 0 
(b) Urine dipstix  
                                                                                  
Yes 1 
                                                                                  
No 0 
 (c) Blood Pressure  




                                                                                  
No 0 
 (2) Was diagnosis based on  
    available clinical data?  
                                                                                 
Yes 1 
                                                                                 
No 0 
  (3)  Was appropriate referral made on those 
diagnosed with PIH?  
                                       Yes 1 
                                       No 0 
    (4) Was basic investigations done for 
patients with PIH?  
                                        (a)       Hemoglobin  
                                                Yes 1 
                                                NO 0 
                                                    (b)         Platelet  
                                                Yes 1 
                                                No 0 
                                                      (c)   Creatinine  
                                                   Yes 1 
                                                No 0 
                                                         (d)     Urea  
                                                 Yes 1 
                                               No 0 
                                                          (e)  AST  
                                                Yes 1 
                                                No 0 
OUTCOME  
Diastolic Blood Pressure  
90-109 mmhg 1 
110 or more 2 





MODE OF DELIVERY  
                                                                               
NVD 1 
                                                                                 
C/S 2 
(1) Were any maternal complications 
documented?  
         (a)  Eclampsia  
               Yes 1 
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               No 0 
      (b) Stroke  
              Yes 1 
            No 0 
       (c) HELLP Syndrome  
            Yes 1 
            No 0 
        (d)  Renal Failure  
            Yes 1 
           No 0 
       (e)  Pulmonary Oedema  
            Yes 1 
            No 0 
         (f)  Maternal Death  
           Yes 1 
           No 0 
(2) Were any fetal complications 
documented?  
     (a) Intrauterine growth restriction  
        Yes 1 
        No 0 
      (b) Fetal Distress  
        Yes 1 
         No 0 
      (c) Abruptio Placentae  
         Yes 1 
         No 0 
          
      (e)  Fetal   Death  
         Yes 1 
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  Appendix B  
         Permission letter to access patient’s record  
13th October 2017. 
The Facility Manager,  
New Somerset Hospital, 
Cape Town. 
RE: REQUEST FOR PERMISSION TO ACCESS THE PATIENTS FOLDER. 
Dear Sir,  
I humbly write to seek your permission to carry out the research project on the clinical audit on the 
quality of care and the outcome of patients with Pregnancy Induced Hypertension in Wesfleur Hospital 
Atlantis- New Somerset Hospital axis, Cape Town. 
This is retrospective clinical audit that will involve reviewing of medical records of patient seen between 
March 2017- August 2017. 
The research will be conducted in accordance with the regulations of Health Research Ethics Committee 
(HREC). 
I am looking forward to your favourable consideration. 
Thank you. 
 DR T.O SOBAMOWO 
Family Medicine and Primary Care, 
University of Cape Town.   
Signature removed to avoid exposure online
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Human Research Ethics Committee Approval 
Signature removed to avoid exposure online
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